Subodh Verma

Research interests

Publications

• Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2313917

• Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

  The Lancet · 2024 · https://doi.org/10.1016/s0140-6736(24)00469-0

• Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2407107

• Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2306963

• Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

  JACC Heart Failure · 2022 · https://doi.org/10.1016/j.jchf.2021.11.006

• Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2206286

• Empagliflozin in Heart Failure with a Preserved Ejection Fraction

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2107038

• Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

  JAMA · 2020 · https://doi.org/10.1001/jama.2020.1906

• The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

  Canadian Journal of Cardiology · 2020 · https://doi.org/10.1016/j.cjca.2020.09.001

• Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2030183

• Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2022190

• Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1911303

• Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

  Circulation · 2019 · https://doi.org/10.1161/circulationaha.119.044138

• Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

  New England Journal of Medicine · 2018 · 10.1056/nejmoa1809798

• 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

  Canadian Journal of Cardiology · 2018 · https://doi.org/10.1016/j.cjca.2018.08.026

• Inflammatory and Cholesterol Risk in the FOURIER Trial

  Circulation · 2018 · https://doi.org/10.1161/circulationaha.118.034032

• The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve–related aortopathy: Full online-only version

  Journal of Thoracic and Cardiovascular Surgery · 2018 · https://doi.org/10.1016/j.jtcvs.2018.02.115

• Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1711818

• Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery

  Journal of the American Society of Nephrology · 2017 · https://doi.org/10.1681/asn.2016101150

• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

  Canadian Journal of Cardiology · 2016 · https://doi.org/10.1016/j.cjca.2016.07.591

• Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy

  Journal of the American College of Cardiology · 2015 · https://doi.org/10.1016/j.jacc.2015.06.1310

Current projects

No projects listed.